Latest News and Press Releases
Want to stay updated on the latest news?
-
The lipid nanoparticle manufacturing market size is set to expand from USD 400 million in 2024 to USD 2243 million by 2034, with a CAGR of 18.9%.
-
The biopharmaceutical third-party logistics market size to grow from USD 143.44 bn in 2024 to USD 276.24 bn by 2034, achieving a CAGR of 6.62%.
-
The cognitive assessment and training in healthcare market is set to expand from USD 8.46 bn in 2025 to USD 73.08 bn by 2034, at a CAGR of 27.06%.
-
Biologics and Cross-Border Trade Drive the Next Phase of Growth in Cold Chain Pharmaceuticals Market
The cold chain pharmaceuticals market size is predicted to grow from USD 6.93 billion in 2026 to USD 9.71 billion by 2035, driven by a CAGR of 3.83%.
-
The clinical data analytics market size is expected to see growth from USD 81.65 billion in 2024 to USD 930.01 billion by 2034, rising at a CAGR of 27.5%.
-
The healthcare enterprise software market size is expected to see growth from USD 43.62 billion in 2024 to USD 158.63 by 2034 expanding at a CAGR of 13.8%.
-
The NFT in healthcare market size is projected to expand from USD 211.26 million in 2024 to USD 1142.77 million by 2034, with a CAGR of 18.34%.
-
The protein therapeutics market is anticipated to grow from USD 375.3 billion in 2024 to USD 740.07 billion by 2034, achieving a CAGR of 7.08%.
-
The E-prescription market size is set to expand from USD 4.71 billion in 2024 to USD 53.17 billion by 2034, with a CAGR of 26.84%.
-
Pharma faces a patent cliff as blockbuster drugs lose exclusivity reshaping markets, driving generics and unlocking new lifecycle and growth strategies.